Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
批准号:
7943137
负责人:
Jaydutt V. Vadgama
金额:
$190.31万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-29 至 2014-08-31
关键词:
African AmericanAgeAmbulatory CareAreaArtsBiologicalBiological MarkersBreast Cancer CellCaliforniaCancer CenterCancer PatientCancer Research ProjectCancer cell lineCategoriesCaucasiansCaucasoid RaceCharacteristicsCharitiesChemopreventive AgentClinicalClinical ResearchClinical TrialsCollectionCommunitiesCommunity HealthCommunity OutreachCounselingDataDatabasesDevelopmentDiagnosisDisadvantagedDiseaseDominant-Negative MutationEconomically Deprived PopulationEducation and OutreachEnvironmentEpidemiologyEthnic groupFacultyFutureGenomicsGoalsGrowthHealthHealth StatusHispanicsImmunohistochemistryInformaticsIntegrinsJonsson Comprehensive Cancer Center of University of California Los AngelesKnowledgeLatinaLeadLeadershipLearningLos AngelesMalignant NeoplasmsMammary Gland ParenchymaMeasuresMedical StudentsMedical centerMentorsMentorshipMinorityMinority GroupsMonoclonal AntibodiesMusNCI Scholars ProgramNational Cancer InstituteOutcomeParaffinPartner in relationshipPathogenesisPathway interactionsPatientsPilot ProjectsPlayPopulationPrevention strategyProcessPrognostic MarkerProtein BindingProteinsRNAResearchResearch InfrastructureResearch PersonnelResearch TrainingResistanceResourcesRoleRunningSamplingScienceServicesStaining methodStainsTechniquesTestingTherapeuticTissue MicroarrayTissuesTrainingTraining ProgramsTransgenic AnimalsTransgenic MiceTransgenic OrganismsUnderserved PopulationUniversitiesValidationWorkanticancer researchbiobankcancer educationcancer health disparitycareercareer developmentchemotherapyevidence baseexperiencehealth disparityhuman FRAP1 proteinin vivoinsightmalignant breast neoplasmnovelnovel therapeutic interventionnovel therapeuticsoutcome forecastoutreachoverexpressionprognostic indicatorprogramsreceptorresearch facilityresponsesocioeconomicstissue resourcetumor progression
中文摘要
查尔斯·德鲁大学(CDU)和加州大学洛杉矶分校琼森癌症中心之间拟议的合作伙伴关系旨在“消除少数民族和服务不足人群的癌症健康差异”。这一目标将继续加强CDU癌症研究和培训基础设施,提高少数民族学生,研究员和教师参与癌症研究,培训和癌症外展。的
伙伴关系将继续招募新的教师与职业重点在癌症研究,教育或推广。
同样,加州大学洛杉矶分校和JCCC的研究人员将有重要的机会来解决与少数群体癌症负担不平等有关的问题。在U 56资助期间建立的合作伙伴关系对我们开发强大的试点和合作伙伴计划的能力产生了重大影响。一个关键的新的和重要的除了我们的U 54计划是强大的癌症外展计划和项目的发展。因此,我们将培训更多的少数民族研究人员,解决我们社区的癌症研究、教育、培训和结果问题。鉴于洛杉矶和加州州人口结构的迅速变化,CDU-UCLA伙伴关系处于理想位置,将有机会对减少癌症发病率和改善少数民族和服务不足人群的生存产生积极影响。
CDU-UCLA癌症合作计划的总体目标是显着增加癌症研究中少数民族科学家的数量,并加强CDU的癌症外展计划,以解决少数民族人群中癌症的显着差异。由行政核心,规划和评估核心和发展核心支持和实施,基本计划组成部分是1)研究项目; 2)学生和初级研究人员的指导; 3)培训研讨会系列; 4)加强CDU的少数民族综合临床和组织生物储存库数据库
5)加强社区参与; 6)改善我们的临床试验资源;和7)增加教师招聘。我们计划提交2个完整的项目和2个试点项目。
英文摘要
The proposed partnership between Charles Drew University (CDU) and UCLA Jonsson Cancer Center seeks to "Eliminate Cancer Health Disparities in Minority and Underserved Populations". This objective will continue to strengthen the CDU cancer research and training infrastructure by enhancing the participation of minority students, fellows and faculty engaged in Cancer Research, Training, and Cancer Outreach. The
partnership will continue to recruit new faculty with career focus in cancer research, education or outreach.
Likewise, UCLA and the investigators in the JCCC will have the important opportunity to address, issues related to the unequal burden of cancer in minority populations. The partnership developed during our U56 funding has made a significant impact on our ability to develop strong pilots and partnership programs. A key new and important addition to our U54 program is the development of strong Cancer Outreach Program and Projects. Thereby, we will train more minority investigators addressing issues in cancer research, education, training and outcome in our communities. In view of the rapidly changing demographics of Los Angeles and the state of California, the CDU-UCLA Partnership is ideally situated and will have an opportunity to have a positive impact on reducing cancer incidence and improving survival in minority and underserved populations.
The overarching goals of the CDU-UCLA Cancer Partnership Program are to significantly increase the number of minority scientists in cancer research and to enhance the cancer outreach programs at CDU to address significant disparities in cancer among minority populations. Supported and implemented by an Administrative Core, Planning and Evaluation Core, and Developmental Core, the basic program components are 1) research projects; 2) the mentoring of students and junior investigators; 3) the training seminar series; 4) enhance CDU's integrated clinical and tissue biorepository data base on minority
suubjects; 5) enhance community participation; 6) improve our clinical trials resource; and 7) increase faculty recruitment. We plan to submit 2 full projects and 2 pilot projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Workshop for Junior Biostatisticians in Health Research
-
批准号:10655012
-
项目类别:
-
资助金额:$7.18万
-
财政年份:2022
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Administrative Core
-
批准号:10173020
-
项目类别:
-
资助金额:$19.2万
-
财政年份:2020
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Accelerating Excellence in Translational Science (AXIS) - Admin Supplement
-
批准号:10212868
-
项目类别:
-
资助金额:$17.94万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
-
批准号:8137688
-
项目类别:
-
资助金额:$188.4万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
-
批准号:8530618
-
项目类别:
-
资助金额:$17.99万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
-
批准号:8720904
-
项目类别:
-
资助金额:$16.82万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Administrative Core
-
批准号:10266212
-
项目类别:
-
资助金额:$17.94万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Administrative Core
-
批准号:10265665
-
项目类别:
-
资助金额:$17.94万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
CDU-UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
-
批准号:9150511
-
项目类别:
-
资助金额:$180.2万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Accelerating Excellence in Translational Science (AXIS)
-
批准号:10283209
-
项目类别:
-
资助金额:$11.62万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Administrative Core
-
批准号:10349520
-
项目类别:
-
资助金额:$64.68万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Accelerating Excellence in Translational Science (AXIS)
-
批准号:10173019
-
项目类别:
-
资助金额:$19.2万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Accelerating Excellence in Translational Science (AXIS)
-
批准号:10212836
-
项目类别:
-
资助金额:$17.94万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Accelerating Excellence in Translational Science (AXIS) - Administrative Supplement
-
批准号:10206613
-
项目类别:
-
资助金额:$24.25万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Developmental Core
-
批准号:7847112
-
项目类别:
-
资助金额:$177.69万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Administrative
-
批准号:7847115
-
项目类别:
-
资助金额:$8.11万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Administrative Core
-
批准号:10567025
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Determining the role of free fatty acids in developing e-cigarette-induced cardiac dysfunction
-
批准号:10560411
-
项目类别:
-
资助金额:$7.18万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Accelerating Excellence in Translational Science (AXIS)
-
批准号:9339824
-
项目类别:
-
资助金额:$27.99万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
Planning and Evaluation
-
批准号:8181108
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2009
-
负责人:Jaydutt V. Vadgama
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: